Integrated micro‐scale protein a chromatography and Low pH viral inactivation unit operations on an automated platform
Biotechnology Progress · 2024
DOI: 10.1002/btpr.3476 ↗At a glance
Journal article in Biotechnology Progress, 2024. Written by Paras Sharma and 4 co-authors. Institution: Department of Biochemical Engineering, University College London, London, UK. Major MEDLINE topics: Virus Inactivation, Staphylococcal Protein A, Antibodies, Monoclonal. Cited 3 times so far (Crossref); 29 references. The full text is freely available (open access, CC BY 4.0). Funded by: Engineering and Physical Sciences Research Council.
Abstract (original language)
High throughput process development (HTPD) is established for time‐ and resource‐ efficient chromatographic process development. However, integration with non‐chromatographic operations within a monoclonal antibody (mAb) purification train is less developed. An area of importance is the development of low pH viral inactivation (VI) that follows protein A chromatography. However, the lack of pH measurement devices at the micro‐scale represents a barrier to implementation, which prevents integration with the surrounding unit operations, limiting overall process knowledge. This study is based upon the design and testing of a HTPD platform for integration of the protein A and low pH VI operations. This was achieved by using a design and simulation software before execution on an automated liquid handler. The operations were successfully translated to the micro‐scale, as assessed by analysis of recoveries and molecular weight content. The integrated platform was then used as a tool to assess the effect of pH on HMWC during low pH hold. The laboratory‐scale and micro‐scale elution pools showed comparable HMWC across the pH range 3.2–3.7. The investigative power of the platform is highlighted by evaluating the resources required to conduct a hypothetical experiment. This results in lower resource demands and increased labor efficiency relative to the laboratory‐scale. For example, the experiment can be conducted in 7 h, compared to 105 h, translating to labor hours, 3 h and 28 h for the micro‐scale and laboratory‐scale, respectively. This presents the opportunity for further integration beyond chromatographic operations within the purification sequence, to establish a fit‐to‐platform assessment tool for mAb process development.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Biochemical Engineering, University College London, London, UK.
- Biopharmaceutical Product Development, CSL Behring Innovation GmbH, Marburg, Germany.
ORCID profiles: Paras Sharma, Daniel G Bracewell
Funding
- Engineering and Physical Sciences Research Council
Cite
APA
Sharma, P., Robbel, L., Schmitt, M., Dikicioglu, D., & Bracewell, D. G. (2024). Integrated micro‐scale protein a chromatography and Low pH viral inactivation unit operations on an automated platform. Biotechnology Progress. https://doi.org/10.1002/btpr.3476
Vancouver
Sharma P, Robbel L, Schmitt M, Dikicioglu D, Bracewell DG. Integrated micro‐scale protein a chromatography and Low pH viral inactivation unit operations on an automated platform. Biotechnology Progress. 2024. doi:10.1002/btpr.3476
BibTeX
@article{Sharma2024,
author = {Sharma, Paras and Robbel, Lars and Schmitt, Michael and Dikicioglu, Duygu and Bracewell, Daniel G},
title = {Integrated micro‐scale protein a chromatography and Low pH viral inactivation unit operations on an automated platform},
journal = {Biotechnology Progress},
year = {2024},
doi = {10.1002/btpr.3476}
}
EUVIMED